FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/23/2024
Back to search
Official data from USPTO
NEWLUX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
04/23/2024
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
05/16/2022
Registration date
12/26/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/26/2023
Last transaction
12/26/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
KR
Examiner
ONUOHA, ALEXANDRIA N
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Medytox Inc.
Representatives
Mark J. Liss Leydig, Voit & Mayer, Ltd.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical agents affecting sensory organs; muscle relaxants; preparations for the treatment of muscle fatigue;pharmaceutical agents affecting peripheral nervous system; vaccines; pharmaceuticals containing botulinum toxin for medical use for use in treatment of excessive sweatingexcessive eye blinkingneuropathy painfacial wrinklesglabellar linesforehead wrinkleslateral canthal linemigraine headacheoveractive bladderurge incontinenceprostate disordercervical dystoniaspasticitymuscle dystoniablepharospasmhyperhidrosisstrabismusneuropathy pain and pelvic pain; bacteria poisons;pharmacological preparations for skin care; chemico-pharmaceutical preparations for skin careskin woundsprevention of migraines; pharmaceutical agents for epidermis; biological preparations for medical or veterinary purposes being bacterial and bacteriological preparations; medicated lotions for skinsunburnfacebody; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; medical infusions for treating migraine headachesexcessive sweatingurinary incontinence; injectable dermal fillers; implantable medicines being medicinal infusionsinjectable gelsinjectable pharmaceuticals for use in the treatment of anaphylactic reactionsmigraine headachesurinary incontinenceneurological disorders and muscle dystonia; pharmaceutical preparations acting on the central nervous system; pain relief medication; dermatological pharmaceutical products; pharmaceutical preparations for treating skin disorders
Publications
History of USPTO decisions and trademark events.
28 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/27/2024
FIMP
FINAL DISPOSITION PROCESSED
03/27/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/26/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/02/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/26/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/26/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/13/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/13/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2023
PUBO
PUBLISHED FOR OPPOSITION
10/10/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/20/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/20/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/08/2023
RFNT
REFUSAL PROCESSED BY IB
03/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/03/2023
RFRR
REFUSAL PROCESSED BY MPU
03/03/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/07/2023
CNRT
NON-FINAL ACTION WRITTEN
01/06/2023
DOCK
ASSIGNED TO EXAMINER
12/28/2022
MAFR
APPLICATION FILING RECEIPT MAILED
07/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/07/2022
Continuous trademark protection
Get notified about every new filing that threatens NEWLUX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.